Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mothercell Regenerative Centre (MCRC) is a clinical-stage regenerative medicine company and clinic based in Tiruchirappalli, Tamil Nadu, India. Founded in 2012, the company focuses on developing and commercializing innovative cell-based therapeutics, including autologous and allogeneic stromal cell therapies. MCRC has developed a biologic platform that harnesses the therapeutic power of chemokines, exosomes, and secretomes to create shelf-stable remedies. The company collaborates with partners like Cipla and Alkem to deliver approved stem cell therapies such as REGENACIP for critical limb ischemia and STEM ONE for knee osteoarthritis. Additionally, MCRC provides services in platelet-rich plasma (PRP) therapy, cell processing, and cryopreservation for various indications including wound healing, infertility, and joint disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mothercell Regenerative Centre.